Agranulocytosis due to Ebstein-Barr Virus (EBV) infection

Main Article Content

Chayapol Sukto
Tirayut Veerasathian
Somchai Insiripong

Abstract

          Agranulocytosis is defined by the state of neutrophil less than 500/mm3. It has been rarely diagnosed but it can be fatal if it is notimmediately recognized and treated.Its common cause is mainly drugs especially anti-thyroid drug. Agranulocytosis due to infections e.g., Epstein-Barr virus (orEBV) has been occasionally reported. Herein, we studied a 3-year-old Thai boy who firstly presented with acute febrile illness, no organ specific symptom. The physical examination revealed only fever while the blood tests showed normal white blood cell (WBC) count but positive for anti-EBV (VCA) IgM. With symptomatic treatment, he could be discharged home within three days. Twenty-six days later, he again suddenly developed acute fever without chill, no organ specific symptom. Besides fever, lymphadenopathy and hepatosplenomegaly were not found on the physical examination. The CBC was studied again, Hb 11.3 g%, Hct 33.5 %, WBC 2,350/mm3, N 3 %, L 96 %, platelet 256,000/mm3, absolute neutrophil count 70.5/mm3. The bone marrow study revealed the normocellularity, with increased histiocytesand evidence of hemophagocytic cells but no hematologic malignancies by the flow cytometry. Two specimens of blood culture for bacteria yielded no growth. He was diagnosed as agranulocytosis possibly related to previous EBV infection. And he was treated with combined antibiotics without colony stimulating factors. He could recover and could be discharged on the 8th day of admission. He has been followed every 6 months for physical examination and CBC for nearly all ten years. He is still healthy without agranulocytosis, Burkitt’s lymphoma or nasopharyngeal carcinoma.

Article Details

How to Cite
Sukto, C. ., Veerasathian, T. ., & Insiripong, S. (2024). Agranulocytosis due to Ebstein-Barr Virus (EBV) infection. Maharat Nakhon Ratchasima Hospital Journal, 40(1), 55–60. Retrieved from https://he04.tci-thaijo.org/index.php/MNRHJ/article/view/1376
Section
Case Report

References

Munshi HG, Montgomery RB. Evidence-based case review, severe neutropenia: a diagnostic approach. West J Med 2000; 172: 248-52.

Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm BE, et al. Drugs in the aetiology of agranulocytosis and aplastic anemia. Eur J Haematol Suppl 1996; 60: 23-30.

Baehner RL. Drug-induced neutropenia and agranulocytosis. In: UpToDate, Basow DS(Ed), UpToDate, Walt-ham MA, 2008.

Kaufman DW, Kelly JP, Levy M, Shapiro S. Drug etiology of agranulocytosis: Update of the International Agranulocytosis and Aplastic Anemia Study. Pharmacoepidem Drug Safety 1993; 2: S25.

Insiripong S. Agranulocytosis in dengue hemorrhagic fever: a neglected condition. J Med Assoc Thai 2010; 93: 502-4.

Apinantriyo B, Lekhakula A, Rujirojindakul P. Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis. Hematol 2011; 16: 50-3.

Lekhakula A, Swasdikul D. Drug-induced agranulocytosis: experience in two university hospitals. J Med Assoc Thai 1991; 74: 121-30.

Neel EU. Infectious mononucleosis death due to agranu-locytosis and pneumonia. JAMA 1976; 236: 1493-4.

Brkić S, Aleksić-Dordević M, Belić A, Jovanović J, Bogdanović M. Agranulocytosis as a complication of acute infectious mononucleosis. Med Pregl 1998; 51: 355-8. [Article in Croatian]

Auvin S, Dalle JH, Ganga-Zandzou PS, Ythier H. Is agranulocytosis following infectious mononucleosis caused by autoimmunity? PediatrHematolOncol 2003; 20: 611-5.

Yokoyama T, Tokuhisa Y, Toga A, Fujiki T, Sakakibara Y, Mase S, et al. Agranulocytosis after infectious mono-nucleosis. J ClinVirol 2013; 56: 355-357.

Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nature Reviews Cancer 2016; 16: 789-802. doi:10.1038/nrc.2016.92

Sullivan JL. Clinical manifestations and treatment of Epstein-Barr virus infection. UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on November 25, 2013.)